Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor

References

• HolohanCVan SchaeybroeckSLongleyDBJohnstonPGCancer drug resistance: an evolving paradigmNat Rev Cancer2013131071472624060863
   PubMed Web of Science ®Google Scholar
• HigginsCFMultiple molecular mechanisms for multidrug resistance transportersNature2007446713774975717429392
   PubMed Web of Science ®Google Scholar
• SunXBaoJShaoYMathematical modeling of therapy-induced cancer drug resistance: connecting cancer mechanisms to population survival ratesSci Rep201662249826928089
   PubMed Web of Science ®Google Scholar
• MoitraKOvercoming multidrug resistance in cancer stem cellsBiomed Res Int2015201563574526649310
   PubMed Web of Science ®Google Scholar
• BrzozowskaNLiKMWangXSABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anti-convulsant drug cannabidiol in micePeerJ20164e208127257556
   PubMed Web of Science ®Google Scholar
• NakanishiTRossDDBreast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expressionChin J Cancer2012312739922098950
   PubMed Web of Science ®Google Scholar
• LukyanovaNYCharacteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cellsExp Oncol2010321101420332764
   PubMedGoogle Scholar
• MaoQUnadkatJDRole of the breast cancer resistance protein (BCRP/ABCG2) in drug transport–an updateAAPS J2015171658225236865
   PubMed Web of Science ®Google Scholar
• LitmanTBrangiMHudsonEThe multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)J Cell Sci2000113Pt 112011202110806112
   PubMed Web of Science ®Google Scholar
• JonkerJWBuitelaarMWagenaarEThe breast cancer resistance protein protects against a major chlorophyll-derived dietary photo-toxin and protoporphyriaProc Natl Acad Sci U S A20029924156491565412429862
   PubMed Web of Science ®Google Scholar
• KwekkeboomRFLeiZDoevendansPAMustersRJSluijterJPTargeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challengesClin Sci (Lond)2014127635136524895056
   PubMed Web of Science ®Google Scholar
• ShiBZhangHBiJDaiSEndosomal pH responsive polymers for efficient cancer targeted gene therapyColloids Surf B Biointerfaces2014119556524880229
   PubMed Web of Science ®Google Scholar
• XueHYLiuSWongHLNanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicineNanomedicine20149229531224552562
   PubMed Web of Science ®Google Scholar
• ThibaultMLavertuMAstolfiMBuschmannMDStructure dependence of lysosomal transit of chitosan-based polyplexes for gene deliveryMol Biotechnol2016581064865627412655
   PubMed Web of Science ®Google Scholar
• GuJChenXXinHFangXShaXSerum-resistant complex nanoparticles functionalized with imidazole-rich polypeptide for gene delivery to pulmonary metastatic melanomaInt J Pharm20144611–255956924370843
   PubMedGoogle Scholar
• LeucutaSESubcellular drug targeting, pharmacokinetics and bioavail-abilityJ Drug Target20142229511524188545
   PubMed Web of Science ®Google Scholar
• YoshidaTLaiTCKwonGSSakoKpH- and ion-sensitive polymers for drug deliveryExpert Opin Drug Deliv201310111497151323930949
   PubMed Web of Science ®Google Scholar
• RaemdonckKMartensTFBraeckmansKDemeesterJDe SmedtSCPolysaccharide-based nucleic acid nanoformulationsAdv Drug Deliv Rev20136591123114723680381
   PubMed Web of Science ®Google Scholar
• KhanINAl-KarimSBoraRSChaudharyAGSainiKSCancer stem cells: a challenging paradigm for designing targeted drug therapiesDrug Discov Today201520101205121626143148
   PubMed Web of Science ®Google Scholar
• MessaoudiKClavreulALagarceFToward an effective strategy in glioblastoma treatment. Part II: RNA interference as a promising way to sensitize glioblastomas to temozolomideDrug Discov Today201520677277925892456
   PubMed Web of Science ®Google Scholar
• MehrotraNTripathiRMShort interfering RNA therapeutics: nanocarriers, prospects and limitationsIET Nanobiotechnol20159638639526647816
   PubMed Web of Science ®Google Scholar
• VicentiniFTBorgheti-CardosoLNDepieriLVDelivery systems and local administration routes for therapeutic siRNAPharm Res201330491593123344907
   PubMed Web of Science ®Google Scholar
• HeyesJPalmerLBremnerKMacLachlanICationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJ Control Release2005107227628716054724
   PubMed Web of Science ®Google Scholar
• AliabadiHMLandryBSunCTangTUludagHSupramolecular assemblies in functional siRNA delivery: where do we stand?Biomaterials20123382546256922209641
   PubMed Web of Science ®Google Scholar
• ShuklaRSTaiWMahatoRJinWChengKDevelopment of streptavidin-based nanocomplex for siRNA deliveryMol Pharm201310124534454524160908
   PubMedGoogle Scholar
• BrownMSHerzJGoldsteinJLLDL-receptor structure. Calcium cages, acid baths and recycling receptorsNature199738866436296309262394
   PubMed Web of Science ®Google Scholar
• VyasSPSihorkarVEndogenous carriers and ligands in non-immunogenic site-specific drug deliveryAdv Drug Deliv Rev2000432–310116410967224
   PubMed Web of Science ®Google Scholar
• HuntosovaVBuzovaDPetrovajovaDDevelopment of a new LDL-based transport system for hydrophobic/amphiphilic drugdelivery to cancer cellsInt J Pharm20124361–246347122814227
   PubMedGoogle Scholar
• ZhengGChenJLiHGlicksonJDRerouting lipoprotein nanopar-ticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agentsProc Natl Acad Sci U S A200510249177571776216306263
   PubMed Web of Science ®Google Scholar
• KaderAPaterALoading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cellsJ Control Release2002801–3294411943385
   PubMed Web of Science ®Google Scholar
• NikanjamMGibbsARHuntCABudingerTFForteTMSynthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiformeJ Control Release2007124316317117964677
   PubMed Web of Science ®Google Scholar
• BeiYYYuanZQZhangLNovel self-assembled micelles based on palmitoyl-trimethyl-chitosan for efficient delivery of harmine to liver cancerExpert Opin Drug Deliv201411684385424655139
   PubMed Web of Science ®Google Scholar
• YuanZQLiJZLiuYSystemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancerInt J Pharm20154921–214115126188316
   PubMedGoogle Scholar
• LunguIIRadulescuMMogosanuGDGrumezescuAMpH sensitive core-shell magnetic nanoparticles for targeted drug delivery in cancer therapyRom J Morphol Embryol2016571233227151685
   PubMed Web of Science ®Google Scholar
• ChenWLYangSDLiFTumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiencyInt J Pharm2016511272874027484835
   PubMed Web of Science ®Google Scholar
• LiJHuoMWangJRedox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxelBiomaterials20123372310232022166223
   PubMed Web of Science ®Google Scholar
• SunYHuangYBianSLiangJFanYZhangXReduction-degradable PEG-b-PAA-b-PEG triblock copolymer micelles incorporated with MTX for cancer chemotherapyColloids Surf B Biointerfaces201311219720323981981
   PubMed Web of Science ®Google Scholar
• ZhangCGZhuQLZhouYN-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumorsInt J Nanomed2014929192932
   PubMed Web of Science ®Google Scholar
• ZhangCGZhuWJLiuYNovel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapySci Rep201662385927030638
   PubMed Web of Science ®Google Scholar
• ZhangCGYangSDZhuWJDistinctive polymer micelle designed for siRNA delivery and reversal of MDR1 gene-dependent multidrug resistanceJ Biomed Mater Res B Appl Biomater Epub2016713
   Web of Science ®Google Scholar
• ZhuQLZhouYGuanMLow-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapyBiomaterials201435225965597624768047
   PubMed Web of Science ®Google Scholar
• YangSDZhuWJZhuQLBinary-copolymer system base on low-density lipoprotein-coupled N-succinyl chitosan lipoic acid micelles for co-delivery MDR1 siRNA and paclitaxel, enhances antitumor effects via reducing drugJ Biomed Mater Res B Appl Biomater Epub2016323
   Web of Science ®Google Scholar
• CaoNChengDZouSAiHGaoJShuaiXThe synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cellsBiomaterials20113282222223221186059
   PubMed Web of Science ®Google Scholar
• SunHMengFChengRDengCZhongZReduction-responsive polymeric micelles and vesicles for triggered intracellular drug releaseAntioxid Redox Signal201421575576724279980
   PubMed Web of Science ®Google Scholar
• KettigerHSchipanskiAWickPHuwylerJEngineered nanomaterial uptake and tissue distribution: from cell to organismInt J Nanomed2013832553269
   PubMed Web of Science ®Google Scholar
• GuoMMaoHLiYDual imaging-guided photothermal/photodynamic therapy using micellesBiomaterials201435164656466624613048
   PubMed Web of Science ®Google Scholar